Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathy

Phytotherapy Research

Volumn 24, Issue 6, 2010, Pages 875-884

  Wojcikowski, Ken ^a,b   Wohlmuth, Hans ^b   Johnson, David W ^a   Gobe, Glenda ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SOUTHERN CROSS UNIVERSITY   (Australia)

Author keywords

A A; Astragalus; Chronic kidney disease; Renal fibrosis; Transcribing growth factor beta 1; UUO

Indexed keywords

ANGELICA SINENSIS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; COLLAGEN; DRINKING WATER; ENALAPRIL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANGELICA SINENSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTRAGALUS MEMBRANACEUS; CELL ACTIVATION; CHRONIC KIDNEY DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FIBROBLAST; FIBROSING ALVEOLITIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MACROPHAGE; MALE; MICROSCOPY; MONOTHERAPY; NONHUMAN; OBSTRUCTIVE UROPATHY; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; TREATMENT RESPONSE; URETER OBSTRUCTION;

ANGELICA SINENSIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ASTRAGALUS MEMBRANACEUS; COLLAGEN; DRUGS, CHINESE HERBAL; ENALAPRIL; FIBROBLASTS; FIBROSIS; KIDNEY TUBULES; MACROPHAGES; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; URETERAL OBSTRUCTION;

ANGELICA SINENSIS; ASTRAGALUS MEMBRANACEUS; RATTUS;

EID: 77953242038     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3038     Document Type: Article

References (33)

1. Cai Q, Li X, Wang H. 2001. Astragali and Angelica protect the kidney against ischemia and reperfusion injury and accelerate recovery. Chin Med J 114: 119-123. (Pubitemid 33611103)
2. el-Dahr SS, Gee J, Dipp S, Hanss BG, Vari RC, Chao J. 1993. Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 264: F874-881.
3. El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR. 2007. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292: F1291-1301.
4. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM. 1997. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12: 43-50.
5. Gaedeke J, Neumayer H-H, Peters H. 2006. Pharmacological management of renal fibrotic disease. Expert Opin Pharmacother 7: 377-386.
6. Gobe GC, Axelsen RA. 1987. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273-281.
7. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S. 2001. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 280: F777-F785.
8. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. 1995. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294.
9. Ma J, Fan S, Chen J, Gu Y, Lin S. 1999. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus. Chin Med J 112: 1068-1072. (Pubitemid 30004512)
10. Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR. 2006. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 131: 182-188.
11. Meng L, Qu L, Tang J, Cai S-Q, Wang H, Li X. 2007. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, enhanced nitric oxide production in obstructed rat kidney. Vascul Pharmacol 47: 174-183.
12. Misseri R, Meldrum DR, Dagher P, Hile K, Rink RC, Meldrum KK. 2004. Unilateral ureteral obstruction induces renal tubular cell production of tumor necrosis factor-alpha independent of inflammatory cell infiltration. J Urology 172: 1595-1599.
13. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J. 2000. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313.
14. Moridaira K, Morrissey J, Fitzgerald M, Gou G, McCracken R, Tolley T. 2003. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction. Am J Physiol Renal Physiol 284: F209-F217. (Pubitemid 35471301)
15. Muchaneta-Kubara EC, el Nahas AM. 1997. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 12: 904-915.
16. Pat B, Hughson MB, Nicol J, Hoy WE, Gobe GC. 2007. A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites. Virchows Arch 450: 41-50.
17. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G. 2005. Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67: 931-943.
18. Prud'homme GJ. 2007. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87: 1077-1091.
19. Ryu M, Kim EH, Chun M, kang S, Shim B, Yu Y-B. 2008. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharmacol 115: 184-193.
20. Taal MW. 2004. Slowing the progression of adult chronic kidney disease: therapeutic advances. Drugs 64: 2273-2289.
21. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S, Lechago J. 1996. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50: 200-207. (Pubitemid 26323714)
22. Vielhauer V, Mayadas TN. 2007. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 27: 286-308.
23. Wang H, Li J, Yu L, Yani Z, Ding W. 2004. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci 74: 1645-1658.
24. Weir MR. 2007. Effects of rennin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther 29: 1803-1824.
25. Wojcikowski K, Johnson DW, Gobe G. 2004. Medicinal herbal extracts - renal friend or foe? Part two: herbal extracts with potential renal benefits. Nephrology 9: 400-405. (Pubitemid 40115967)
26. Wojcikowski K, Johnson DW, Gobe G. 2006. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med 147: 160-166.
27. Wojcikowski K, Wohlmuth H, Johnson DW, Rolfe M, Gobe G. 2009. An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects. Nephrology 14: 70-79.
28. Wolf G. 2006. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919.
29. Xie C-H, Zhang M-S, Zhou Y-F, Han G, Cao Z, Zhou F-X. 2006. Chinese medicine Angelica sinensis suppresses radiation-induced expression of TNF-alpha and TGF-beta1 in mice. Oncol Rep 15: 1429-1436.
30. Zhang YW, Xie D, Chen YX, Zhang HY, Xia ZX. 2006a. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats. Exp Clin Endocrinol Diabetes 114: 563-568.
31. Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT. 2006b. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Horm Metab Res 38: 82-88.
32. Zhao J-R, Qu L, Li X-M. 2004. Preventive and therapeutic effects of Astragalus and Angelica mixture on renal tubulointerstitial fibrosis after unilateral ureteral obstruction in rats. (Article in Chinese) Beijing da Xue Xue Bao Yi Xue Ban/ Journal of Peking University. Health Sciences. 36: 119-123.
33. Zhao Y-N, Li J-Z, Yu L. 2002. Effect of Astragalus-Angelica mixture on osteopontin expression in rats with chronic nephrosclerosis. (Article in Chinese) Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi/Chinese Journal of Integrated Traditional and Western Medicine/ Zhongguo Zhong Xi Yi Jie He Xue Hui, Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban 22: 613-617.